-
Taxonomy & unit
-
us-gaap: GBP
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
TC BioPharm (Holdings) plc annual/quarterly Operating Income (Loss) history and growth rate from Q1 2023 to Q1 2024.
- TC BioPharm (Holdings) plc Operating Income (Loss) for the quarter ending March 31, 2024 was -£3.44M, a 17.4% increase year-over-year.
- TC BioPharm (Holdings) plc annual Operating Income (Loss) for 2024 was -£12.8M, a 10.3% increase from 2023.
- TC BioPharm (Holdings) plc annual Operating Income (Loss) for 2023 was -£14.2M, a 17.8% decline from 2022.
Operating Income (Loss), Quarterly (GBP)
Operating Income (Loss), YoY Quarterly Growth (%)